Sustained beneficial effects of enalapril in Africans with congestive heart failure
- 1 October 1990
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 29 (1) , 55-61
- https://doi.org/10.1016/0167-5273(90)90273-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Aspects of molecular biology and biochemistry of the cardiac renin‐ angiotensin system.British Journal of Clinical Pharmacology, 1989
- Enalapril in African patients with congestive cardiac failure.British Journal of Clinical Pharmacology, 1989
- Enalapril and hydrochlorothiazide in hypertensive AfricansEuropean Journal of Clinical Pharmacology, 1989
- SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILUREThe Lancet, 1986
- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTUREThe Lancet, 1985
- Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertensionClinical Pharmacology & Therapeutics, 1984
- An overview of the clinical pharmacology of enalapril.British Journal of Clinical Pharmacology, 1984
- Factors affecting the heart rate during self-paced walkingEuropean Journal of Applied Physiology, 1982
- Racial differences in blood pressure: genetic and environmental factorsPublished by Oxford University Press (OUP) ,1981
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977